Common signs include persistent low mood or irritability, loss of interest in activities, changes in sleep or appetite, fatigue, trouble concentrating, feelings of worthlessness or guilt, and thoughts of death or self-harm. NICE guidance emphasizes careful identification and assessment in ages 5–18 and recommends a structured, stepped-care approach.
Most guidelines position psychotherapy as a core first-line treatment, especially for mild to moderate depression, with more intensive care added as severity increases.
Some teens benefit from therapies that include distress tolerance and safety skills (often DBT-informed). The clinician tailors the approach based on risk and functional impairment.
Even when the teen has individual therapy, family sessions can be essential, improving communication, reducing conflict, strengthening problem-solving, and aligning the home environment with recovery goals. NICE emphasizes building a supportive and collaborative relationship with the teen and family/carers.
For moderate-to-severe depression, persistent symptoms, or insufficient response to therapy alone, clinicians may consider antidepressant medication, typically an SSRI often in combination with therapy. AACAP’s clinical practice guideline discusses SSRIs (with cautions and monitoring) and supports combination options in some cases.
The FDA requires warnings that antidepressants may increase suicidal thinking/behavior in some children and adolescents especially early in treatment or when the dose changes, so careful follow-up and monitoring are essential.
Disclaimer: The information provided on this page is for educational and informational purposes only and is not intended to replace professional medical advice, diagnosis, or treatment. Mental health conditions can present differently in each individual. Treatment decisions should always be made in consultation with a qualified mental health professional who can evaluate a person’s specific needs.